| __timestamp | Ascendis Pharma A/S | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 4534000000 |
| Thursday, January 1, 2015 | 40528000 | 5920000000 |
| Friday, January 1, 2016 | 66022000 | 4940000000 |
| Sunday, January 1, 2017 | 99589000 | 6411000000 |
| Monday, January 1, 2018 | 140281000 | 6345000000 |
| Tuesday, January 1, 2019 | 191621000 | 6148000000 |
| Wednesday, January 1, 2020 | 260904000 | 11143000000 |
| Friday, January 1, 2021 | 295867000 | 10195000000 |
| Saturday, January 1, 2022 | 379624000 | 9509000000 |
| Sunday, January 1, 2023 | 413454000 | 9299000000 |
| Monday, January 1, 2024 | 307004000 | 11159000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Bristol-Myers Squibb Company and Ascendis Pharma A/S have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Bristol-Myers Squibb consistently allocated substantial resources to R&D, peaking in 2020 with a staggering $11.1 billion. This commitment underscores their strategy to maintain a competitive edge in the global market.
In contrast, Ascendis Pharma's R&D spending grew exponentially, increasing by over 2,000% from 2014 to 2023. This growth reflects their aggressive pursuit of innovation and expansion in the biotech sector.
These insights reveal the diverse strategies of established giants and ambitious newcomers in the pharmaceutical industry.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.